A cornucopia of manufacturing reports

 It's time to get that turkey in the oven. But before you do, consider the manufacturing and related reports assembled here.

They cover warning letters and consent decrees, drug distributors, counterfeit drugs and cargo theft. We went in-depth on these topics because they're the ones that appear to interest you most, based on our analysis of website traffic.

Here's to you and yours on Thanksgiving, and thank you for reading! - George (email)

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.